Get the Stockscreener App
44.41
1.49%
0.65
After Hours:
44.41
Omnicell Inc stock is traded at $44.41, with a volume of 281.63K.
It is up +1.49% in the last 24 hours and up +21.17% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$43.76
Open:
$44.01
24h Volume:
281.63K
Relative Volume:
0.49
Market Cap:
$2.02B
Revenue:
$1.23B
Net Income/Loss:
$20.43M
P/E Ratio:
100.68
EPS:
0.4411
Net Cash Flow:
$95.39M
1W Performance:
+2.99%
1M Performance:
+21.17%
6M Performance:
+23.36%
1Y Performance:
+53.99%
1-Day Range:
$43.91
$44.66
1-Week Range:
$42.46
$45.00
52-Week Range:
$26.84
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
44.41 | 1.99B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-26 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-08-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch - Yahoo! Finance Canada
Should You Buy Omnicell (OMCL) After Golden Cross? - Yahoo Finance
Why Omnicell Stock Crushed the Market Today - MSN
Omnicell Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Omnicell (OMCL) Issues Recall for Specific Syringe Labels - GuruFocus
Which Is a Better Investment, Axogen, Inc. or Omnicell, Inc. Stock? - AAII
How Much Upside is Left in Omnicell (OMCL)? Wall Street Analysts Think 39.87% - Yahoo Finance
Omnicell EVP Corey Manley sells $217,180 in OMCL shares By Investing.com - Investing.com Australia
Omnicell EVP Corey Manley sells $217,180 in OMCL shares - Investing.com
Omnicell (OMCL) COO reports 3,090-share sale and RSU tax withholding - Stock Titan
Omnicell (OMCL) officer has 226 shares withheld to cover RSU taxes - Stock Titan
Omnicell (OMCL) EVP Manley sells 5,025 shares, 4,041 withheld for taxes - Stock Titan
Omnicell (OMCL) CEO uses 12,347 shares to cover RSU tax withholding - Stock Titan
Is Analyst Optimism And Wellington’s Stake Reshaping The Investment Case For Omnicell (OMCL)? - Sahm
OMCL (NASDAQ) director files to sell 5,025 vested shares via Fidelity - Stock Titan
[144] OMNICELL, INC. SEC Filing - Stock Titan
Dana Investment Advisors Inc. Purchases New Shares in Omnicell, Inc. $OMCL - MarketBeat
Omnicell Inc stock (US6821321088): pharmacy automation specialist after latest earnings update - AD HOC NEWS
Omnicell Stock Analysis: Is It a Buy or a Portfolio Risk After 23% Gain?News and Statistics - IndexBox
Omnicell (OMCL) is a great momentum stock: Should you buy? - MSN
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead - Yahoo Finance
Wellington affiliates hold 5.96% of Omnicell (OMCL) common stock - Stock Titan
OMCL News | OMNICELL INC (NASDAQ:OMCL) - ChartMill
Avoiding Lag: Real-Time Signals in (OMCL) Movement - Stock Traders Daily
Here is What Analysts Are Saying About Omnicell, Inc. (OMCL) - Insider Monkey
What is Zacks Research's Estimate for Omnicell Q2 Earnings? - MarketBeat
Omnicell's (NASDAQ:OMCL) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Omnicell's (NASDAQ:OMCL) Conservative Accounting Might Explain Soft Earnings - simplywall.st
Some Investors May Be Willing To Look Past Omnicell's (NASDAQ:OMCL) Soft Earnings - 富途牛牛
BofA Securities Maintains Omnicell(OMCL.US) With Buy Rating, Maintains Target Price $70 - Moomoo
What Can You Expect From Omnicell Inc (OMCL) Stock After Solid Q1? - Insider Monkey
Omnicell (NASDAQ:OMCL) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
Omnicell lifts 2026 non-GAAP EPS outlook to $1.80-$2.00 as Titan XT shipments are planned for 2H 2026 - MSN
Q3 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
Q2 2025 Omnicell Inc Earnings Call Transcript - GuruFocus
Vanguard Group Inc. Has $251.55 Million Holdings in Omnicell, Inc. $OMCL - MarketBeat
Here's why Omnicell (OMCL) is a strong momentum stock - MSN
Pharmacy Automation Systems Market to Get an Explosive Growth | - openPR.com
Is It Time To Reassess Omnicell (OMCL) After Its 71% One Year Share Price Rebound - Yahoo Finance
Omnicell Names Former KU Health System Exec as Its Chief Pharmacy and Clinical Officer - Dallas Innovates
Here's Why Omnicell (OMCL) is a Strong Momentum Stock - Yahoo Finance
Omnicell (NASDAQ: OMCL) returns to profit with stronger Q1 2026 cash flow - Stock Titan
Omnicell | 10-Q: Q1 2026 Earnings Report - Moomoo
Wall Street analysts see a 41.19% upside in Omnicell (OMCL): Can the stock really move this high? - MSN
Omnicell (OMCL) Q1 2026 Earnings Transcript - AOL.com
Omnicell, Inc. Experiences Valuation Adjustment Amid Strong Market Performance Metrics - Markets Mojo
Omnicell (OMCL) Is Up 13.7% After Earnings Beat, Raised Guidance, And Key Pharmacy HireWhat's Changed - Sahm
North America Central Fill Pharmacy Automation Market Growth - openPR.com
Zacks Industry Outlook Highlights Veeva Systems, Doximity and Omnicell - Yahoo Finance
Surging earnings estimates signal upside for Omnicell (OMCL) stock - MSN
The 5 Most Interesting Analyst Questions From Omnicell’s Q1 Earnings Call - TradingView
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
4.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):